FdaApplication
ANDA 215893
Identifiers
- fda_app_no: ANDA215893
Properties
| Property | Value |
|---|---|
| applicant_name | APOTEX INC |
| application_type | ANDA |
| approval_date | 2023-07-14 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PONATINIB HYDROCHLORIDE | PONATINIB HYDROCHLORIDE | EQ 45MG BASE | TABLET;ORAL |
| PONATINIB HYDROCHLORIDE | PONATINIB HYDROCHLORIDE | EQ 15MG BASE | TABLET;ORAL |
2 products